• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌患者的骨髓微转移:一项长期随访研究。

Bone Marrow Micrometastases in Breast Cancer Patients: A Long-Term Follow-up Study.

作者信息

Molino Annamaria, Giovannini Monica, Micciolo Rocco, Auriemma Alessandra, Fiorio Elena, Santo Antonio, Cetto Gian Luigi

机构信息

Department of Medical Oncology, University of Verona, Verona, Italy.

出版信息

Clin Med Oncol. 2008;2:487-90. Epub 2008 Sep 4.

PMID:21892323
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3161681/
Abstract

In 125 early breast cancer patients who underwent multiple bone marrow aspirates, there was no significant difference in terms of disease-free and overall survival after a median follow-up of 163 months between the patients with or without micrometastasis at the time of primary surgery. However, when the time-dependent evolution of the bone marrow aspirates was taken into account, some evidence for a longer disease-free and overall survival was found for the patients with negative bone marrow.

摘要

在125例接受多次骨髓穿刺的早期乳腺癌患者中,在对主要手术时有无微转移的患者进行了163个月的中位随访后,其无病生存期和总生存期并无显著差异。然而,当考虑骨髓穿刺的时间依赖性演变时,发现骨髓阴性的患者有更长无病生存期和总生存期的一些证据。

相似文献

1
Bone Marrow Micrometastases in Breast Cancer Patients: A Long-Term Follow-up Study.乳腺癌患者的骨髓微转移:一项长期随访研究。
Clin Med Oncol. 2008;2:487-90. Epub 2008 Sep 4.
2
Outcome of primary-breast-cancer patients with micrometastases: a long-term follow-up study.伴有微转移的原发性乳腺癌患者的预后:一项长期随访研究。
Lancet. 1999 Jul 17;354(9174):197-202. doi: 10.1016/s0140-6736(98)10175-7.
3
The fate of bone marrow micrometastases in patients with primary breast cancer.
J Clin Oncol. 1989 Apr;7(4):445-9. doi: 10.1200/JCO.1989.7.4.445.
4
Bone marrow micrometastases do not impact disease-free and overall survival in early stage sentinel lymph node-negative breast cancer patients.早期前哨淋巴结阴性乳腺癌患者骨髓微转移不影响无病生存和总生存。
Ann Surg Oncol. 2014 Feb;21(2):401-7. doi: 10.1245/s10434-013-3315-9. Epub 2013 Oct 22.
5
Comparative analysis of micrometastasis to the bone marrow and lymph nodes of node-negative breast cancer patients receiving no adjuvant therapy.未接受辅助治疗的淋巴结阴性乳腺癌患者骨髓和淋巴结微转移的对比分析
J Clin Oncol. 2001 Mar 1;19(5):1468-75. doi: 10.1200/JCO.2001.19.5.1468.
6
Association of tumor angiogenesis with bone marrow micrometastases in breast cancer patients.乳腺癌患者肿瘤血管生成与骨髓微转移的相关性
J Natl Cancer Inst. 1997 Jul 16;89(14):1044-9. doi: 10.1093/jnci/89.14.1044.
7
The value of bone marrow aspirates culture for the detection of bone marrow micrometastasis in breast cancer.骨髓穿刺培养在检测乳腺癌骨髓微转移中的价值。
Biomed Pharmacother. 2005 Oct;59 Suppl 2:S384-6. doi: 10.1016/s0753-3322(05)80084-8.
8
Micrometastases in axillary lymph nodes and bone marrow of lymph node-negative breast cancer patients--prognostic relevance after 10 years.淋巴结阴性乳腺癌患者腋窝淋巴结和骨髓中的微转移——10年后的预后相关性
Anticancer Res. 2003 Sep-Oct;23(5b):4319-24.
9
Bone marrow micrometastases in breast cancer patients.乳腺癌患者的骨髓微转移
Breast Cancer Res Treat. 1999 Nov;58(2):123-30. doi: 10.1023/a:1006336100142.
10
Bone marrow micrometastases in primary breast cancer: prognostic significance after 6 years' follow-up.
Eur J Cancer. 1991;27(12):1552-5. doi: 10.1016/0277-5379(91)90413-8.

本文引用的文献

1
Bone marrow cells in the 'pre-metastatic niche': within bone and beyond.“转移前生态位”中的骨髓细胞:骨内及骨外
Cancer Metastasis Rev. 2006 Dec;25(4):521-9. doi: 10.1007/s10555-006-9036-9.
2
The clinical significance of disseminated tumor cells in breast cancer.乳腺癌中播散肿瘤细胞的临床意义。
Nat Clin Pract Oncol. 2007 Jan;4(1):30-41. doi: 10.1038/ncponc0685.
3
Significance, detection and markers of disseminated breast cancer cells.弥漫性乳腺癌细胞的意义、检测及标志物
Endocr Relat Cancer. 2006 Dec;13(4):1033-67. doi: 10.1677/ERC-06-0001.
4
Recent translational research: circulating tumor cells in breast cancer patients.近期转化研究:乳腺癌患者的循环肿瘤细胞
Breast Cancer Res. 2006;8(5):110. doi: 10.1186/bcr1541.
5
Disseminated tumor cells in breast cancer: detection, characterization and clinical relevance.乳腺癌中的播散肿瘤细胞:检测、特征及临床相关性
Future Oncol. 2006 Aug;2(4):553-61. doi: 10.2217/14796694.2.4.553.
6
Prognostic significance of disseminated tumor cells as detected by quantitative real-time reverse-transcriptase polymerase chain reaction in patients with breast cancer.定量实时逆转录聚合酶链反应检测到的播散肿瘤细胞在乳腺癌患者中的预后意义
Clin Breast Cancer. 2006 Jun;7(2):146-52. doi: 10.3816/CBC.2006.n.024.
7
The value of bone marrow aspirates culture for the detection of bone marrow micrometastasis in breast cancer.骨髓穿刺培养在检测乳腺癌骨髓微转移中的价值。
Biomed Pharmacother. 2005 Oct;59 Suppl 2:S384-6. doi: 10.1016/s0753-3322(05)80084-8.
8
Real-time RT-PCR detection of disseminated tumour cells in bone marrow has superior prognostic significance in comparison with circulating tumour cells in patients with breast cancer.与乳腺癌患者的循环肿瘤细胞相比,实时逆转录聚合酶链反应检测骨髓中的播散肿瘤细胞具有更高的预后意义。
Br J Cancer. 2006 Mar 13;94(5):672-80. doi: 10.1038/sj.bjc.6602985.
9
Prognostic relevance of disseminated tumor cells in the bone marrow and biological factors of 265 primary breast carcinomas.265例原发性乳腺癌患者骨髓中播散肿瘤细胞的预后相关性及生物学因素
Breast Cancer Res. 2005;7(6):R1174-85. doi: 10.1186/bcr1360. Epub 2005 Nov 24.
10
A pooled analysis of bone marrow micrometastasis in breast cancer.乳腺癌骨髓微转移的汇总分析。
N Engl J Med. 2005 Aug 25;353(8):793-802. doi: 10.1056/NEJMoa050434.